{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,25]],"date-time":"2026-01-25T12:56:31Z","timestamp":1769345791469,"version":"3.49.0"},"reference-count":54,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2018,9,28]],"date-time":"2018-09-28T00:00:00Z","timestamp":1538092800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100004328","name":"Genentech","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004328","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,1,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Discussions regarding palliative care and end-of-life care issues are frequently delayed past the time of usefulness, resulting in unwanted medical care. We sought to develop a patient-reported outcome (PRO) instrument that allows patients to voice their symptom burdens and facilitate timing of discussions.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Subjects, Materials, and Methods<\/jats:title>\n                  <jats:p>A seven-item PRO instrument (Cota Patient Assessed Symptom Score-7 item [CPASS-7]) covering physical performance status, pain, burden, and depression was administered (September 2015 through October 2016) with correlation to overall survival, correcting for time to complete survey since diagnosis.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>A total of 1,191 patients completed CPASS-7 at a median of 560 days following the diagnosis of advanced cancer. Of these patients, 49% were concerned that they could not do the things they wanted; 35% reported decreased performance status. Financial toxicity was reported by 39% of patients, with family burdens noted in 25%. Although depression was reported by 15%, 43% reported lack of pleasure. Pain was reported by 33%. The median CPASS-7 total symptom burden score was 16 (possible 0\u2013112). With a median follow-up of 15 months from initial survey, 46% had died. Patients with symptom burden scores &amp;lt;29 and \u226529 had a 6-month overall survival rate of 87% and 67%, respectively, and 12-month survival rates of 72% and 50%. A one-point score increase resulted in a 1.8% increase in expected hazard.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Patients with advanced cancer with higher levels of symptom burden, as self-reported on the CPASS-7, had inferior survival. The PRO facilitates identification of patients appropriate for reassessment of treatment goals and potentially palliative and end-of-life care in response to symptom burden concerns.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Implications for Practice<\/jats:title>\n                  <jats:p>A seven-item patient-reported outcome (PRO) instrument was administered to 1,191 patients with advanced cancers. Patients self-reporting higher levels of physical and psychological symptom burden had inferior overall survival rates. High individual item symptom PRO responses should serve as a useful trigger to initiate supportive interventions, but when scores indicate global problems, discussions regarding end-of-life care might be appropriate.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1634\/theoncologist.2018-0238","type":"journal-article","created":{"date-parts":[[2018,9,28]],"date-time":"2018-09-28T17:43:36Z","timestamp":1538156616000},"page":"76-85","source":"Crossref","is-referenced-by-count":20,"title":["A Patient-Reported Outcome Instrument to Assess Symptom Burden and Predict Survival in Patients with Advanced Cancer: Flipping the Paradigm to Improve Timing of Palliative and End-of-Life Discussions and Reduce Unwanted Health Care Costs"],"prefix":"10.1093","volume":"24","author":[{"given":"Stuart L.","family":"Goldberg","sequence":"first","affiliation":[{"name":"Cota Inc, New York, New York, USA"},{"name":"John Theurer Cancer Center at Hackensack University Medical Center, Hackensack, New Jersey, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dhakshila","family":"Paramanathan","sequence":"additional","affiliation":[{"name":"Cota Inc, New York, New York, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raya","family":"Khoury","sequence":"additional","affiliation":[{"name":"Genentech, South San Francisco, California, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharmi","family":"Patel","sequence":"additional","affiliation":[{"name":"Genentech, South San Francisco, California, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dayo","family":"Jagun","sequence":"additional","affiliation":[{"name":"Genentech, South San Francisco, California, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Srikesh","family":"Arunajadai","sequence":"additional","affiliation":[{"name":"Cota Inc, New York, New York, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victoria","family":"DeVincenzo","sequence":"additional","affiliation":[{"name":"Cota Inc, New York, New York, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruth Pe","family":"Benito","sequence":"additional","affiliation":[{"name":"Cota Inc, New York, New York, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brooke","family":"Gruman","sequence":"additional","affiliation":[{"name":"Cota Inc, New York, New York, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sukhi","family":"Kaur","sequence":"additional","affiliation":[{"name":"Cota Inc, New York, New York, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott","family":"Paddock","sequence":"additional","affiliation":[{"name":"Cota Inc, New York, New York, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew D.","family":"Norden","sequence":"additional","affiliation":[{"name":"Cota Inc, New York, New York, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric V.","family":"Schultz","sequence":"additional","affiliation":[{"name":"Cota Inc, New York, New York, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Hervey","sequence":"additional","affiliation":[{"name":"Cota Inc, New York, New York, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Terrill","family":"Jordan","sequence":"additional","affiliation":[{"name":"Regional Cancer Care Associates, Hackensack, New Jersey, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andre","family":"Goy","sequence":"additional","affiliation":[{"name":"John Theurer Cancer Center at Hackensack University Medical Center, Hackensack, New Jersey, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew L.","family":"Pecora","sequence":"additional","affiliation":[{"name":"Cota Inc, New York, New York, USA"},{"name":"Hackensack Meridian Healthcare, Edison, New Jersey, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2018,9,28]]},"reference":[{"key":"2021122506215269900_onco12710-bib-0001","volume-title":"Improving Palliative Care for Cancer","author":"Institute of Medicine (IOM)","year":"2001"},{"key":"2021122506215269900_onco12710-bib-0002","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1001\/archinternmed.2009.127","article-title":"Discussions with physicians about hospice among patients with metastatic lung cancer","volume":"169","author":"Huskamp","year":"2009","journal-title":"Arch Intern Med"},{"key":"2021122506215269900_onco12710-bib-0003","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1089\/jpm.2010.0434","article-title":"Quality of end-of-life care for patients with advanced cancer in an academic medical center","volume":"14","author":"Dy","year":"2011","journal-title":"J Palliat Med"},{"key":"2021122506215269900_onco12710-bib-0004","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1200\/JCO.2012.42.4564","article-title":"Reasons why physicians do not have discussions about poor prognosis, why it matters, and what can be improved","volume":"30","author":"Mack","year":"2012","journal-title":"J Clin Oncol"},{"key":"2021122506215269900_onco12710-bib-0005","doi-asserted-by":"crossref","first-page":"204","DOI":"10.7326\/0003-4819-156-3-201202070-00008","article-title":"End-of-life care discussions among patients with advanced cancer: A cohort study","volume":"156","author":"Mack","year":"2012","journal-title":"Ann Intern Med"},{"key":"2021122506215269900_onco12710-bib-0006","doi-asserted-by":"crossref","first-page":"e0122321","DOI":"10.1371\/journal.pone.0122321","article-title":"No easy talk: A mixed methods study of doctor reported barriers to conducting effective end-of-life conversations with diverse patients","volume":"10","author":"Periyakoil","year":"2015","journal-title":"PLoS One"},{"key":"2021122506215269900_onco12710-bib-0007","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1136\/bmj.327.7408.195","article-title":"A systematic review of physicians' survival predictions in terminally ill cancer patients","volume":"327","author":"Glare","year":"2003","journal-title":"BMJ"},{"key":"2021122506215269900_onco12710-bib-0008","first-page":"22","article-title":"The accuracy of clinicians' predictions of survival in advanced cancer: A review","volume":"5","author":"Cheon","year":"2016","journal-title":"Ann Palliat Med"},{"key":"2021122506215269900_onco12710-bib-0009","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/0003-4819-127-1-199707010-00001","article-title":"Patient preferences for communication with physicians about end-of-life decisions. SUPPORT Investigators. Study to Understand Prognoses and Preference for Outcomes and Risks of Treatment","volume":"127","author":"Hofmann","year":"1997","journal-title":"Ann Intern Med"},{"key":"2021122506215269900_onco12710-bib-0010","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1136\/bmj.320.7239.909","article-title":"Cancer patients' information needs and information seeking behavior: In depth interview study","volume":"320","author":"Leydon","year":"2000","journal-title":"BMJ"},{"key":"2021122506215269900_onco12710-bib-0011","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1200\/JCO.2004.04.095","article-title":"Cancer patient preferences for communication of prognosis in the metastatic setting","volume":"22","author":"Hagerty","year":"2004","journal-title":"J Clin Oncol"},{"key":"2021122506215269900_onco12710-bib-0012","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1200\/JCO.2009.24.6397","article-title":"Paradoxes in advance care planning: The complex relationship of oncology patients, their physicians, and advance medical directives","volume":"28","author":"Dow","year":"2010","journal-title":"J Clin Oncol"},{"key":"2021122506215269900_onco12710-bib-0013","volume-title":"Being Mortal","author":"Gawande","year":"2014"},{"key":"2021122506215269900_onco12710-bib-0014","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1089\/jpm.2000.3.27","article-title":"Paradoxes in cancer patients' advance care planning","volume":"3","author":"Lamont","year":"2000","journal-title":"J Palliat Med"},{"key":"2021122506215269900_onco12710-bib-0015","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1001\/jama.299.22.2667","article-title":"The role of chemotherapy at the end of life: \u201cWhen is enough, enough?\u201d","volume":"299","author":"Harrington","year":"2008","journal-title":"JAMA"},{"key":"2021122506215269900_onco12710-bib-0016","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1001\/jama.300.14.1665","article-title":"Associations between EOL discussions, patient mental health, medical care near death, and caregiver bereavement adjustment","volume":"300","author":"Wright","year":"2008","journal-title":"JAMA"},{"key":"2021122506215269900_onco12710-bib-0017","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1200\/JOP.2011.000394","article-title":"Benchmarks for value in cancer care: An analysis of a large commercial population","volume":"7","author":"Kolodziej","year":"2011","journal-title":"J Oncol Pract"},{"key":"2021122506215269900_onco12710-bib-0018","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1001\/archinte.162.15.1722","article-title":"Managed care, hospice use, site of death, and medical expenditures in the last year of life","volume":"162","author":"Emanuel","year":"2002","journal-title":"Arch Intern Med"},{"key":"2021122506215269900_onco12710-bib-0019","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/j.1475-6773.2004.00232.x","article-title":"Trends in inpatient treatment intensity among Medicare beneficiaries at the end of life","volume":"39","author":"Barnato","year":"2004","journal-title":"Health Serv Res"},{"key":"2021122506215269900_onco12710-bib-0020","doi-asserted-by":"crossref","first-page":"75s","DOI":"10.1200\/JOP.2011.000469","article-title":"Health care costs for patients with cancer at the end of life","volume":"8","author":"Chastek","year":"2012","journal-title":"J Oncol Pract"},{"key":"2021122506215269900_onco12710-bib-0021","doi-asserted-by":"crossref","first-page":"e889","DOI":"10.1200\/JOP.2017.021683","article-title":"End-of-life services among patients with cancer: Evidence from cancer registry records linked with commercial health insurance claims","volume":"13","author":"McDermott","year":"2017","journal-title":"J Oncol Pract"},{"key":"2021122506215269900_onco12710-bib-0022","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1177\/0269216314533813","article-title":"Retrospective studies of end-of-life resource utilization and costs in cancer care using health administrative data: A systematic review","volume":"28","author":"Langton","year":"2014","journal-title":"Palliat Med"},{"key":"2021122506215269900_onco12710-bib-0023","doi-asserted-by":"crossref","first-page":"639","DOI":"10.7326\/0003-4819-138-8-200304150-00011","article-title":"Chemotherapy use among Medicare beneficiaries at the end of life","volume":"138","author":"Emanuel","year":"2003","journal-title":"Ann Intern Med"},{"key":"2021122506215269900_onco12710-bib-0024","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1001\/archinternmed.2008.587","article-title":"Health care costs in the last week of life: Associations with end-of-life conversations","volume":"169","author":"Zhang","year":"2009","journal-title":"Arch Intern Med"},{"issue":"suppl 1","key":"2021122506215269900_onco12710-bib-0025","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1080\/10810730902806786","article-title":"Communication in end-stage cancer: Review of the literature and future research","volume":"14","author":"Trice","year":"2009","journal-title":"J Health Commun"},{"key":"2021122506215269900_onco12710-bib-0026","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1200\/JCO.2009.25.4672","article-title":"End-of-life discussions, goal attainment, and distress at the end of life: Predictors and outcomes of receipt of care consistent with preferences","volume":"28","author":"Mack","year":"2010","journal-title":"J Clin Oncol"},{"key":"2021122506215269900_onco12710-bib-0027","doi-asserted-by":"crossref","first-page":"4656","DOI":"10.1002\/cncr.25217","article-title":"Influence of patients' preferences and treatment site on cancer patients' end-of-life care","volume":"116","author":"Wright","year":"2010","journal-title":"Cancer"},{"key":"2021122506215269900_onco12710-bib-0028","doi-asserted-by":"crossref","first-page":"4823","DOI":"10.1200\/JCO.2004.12.056","article-title":"Diagnostic accuracy of the palliative prognostic score in hospitalized patients with advanced cancer","volume":"22","author":"Glare","year":"2004","journal-title":"J Clin Oncol"},{"key":"2021122506215269900_onco12710-bib-0029","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/j.ejca.2008.02.030","article-title":"Predicting survival in patients with advanced disease","volume":"44","author":"Glare","year":"2008","journal-title":"Eur J Cancer"},{"key":"2021122506215269900_onco12710-bib-0030","first-page":"CD001431","article-title":"Decision aids for people facing health treatment or screening decisions","volume":"1","author":"Stacey","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"2021122506215269900_onco12710-bib-0031","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1136\/bmjspcare-2014-000770","article-title":"Development of a tool for defining and identifying the dying patient in hospital: Criteria for Screening and Triaging to Appropriate aLternative care (CriSTAL)","volume":"5","author":"Cardona-Morrell","year":"2015","journal-title":"BMJ Support Palliat Care"},{"key":"2021122506215269900_onco12710-bib-0032","author":"CMS.gov"},{"key":"2021122506215269900_onco12710-bib-0033","author":"Quality Payment Program","year":"2016"},{"key":"2021122506215269900_onco12710-bib-0034","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1200\/JCO.2016.70.1474","article-title":"Integration of palliative care into standard oncology care: American Society of Clinical Oncology Clinical Practice Guideline Update","volume":"35","author":"Ferrell","year":"2017","journal-title":"J Clin Oncol"},{"key":"2021122506215269900_onco12710-bib-0035","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1001\/jama.2017.7156","article-title":"Overall survival results of a trial assessing patient-reported outcomes for symptom monitoring during routine cancer treatment","volume":"318","author":"Basch","year":"2017","journal-title":"JAMA"},{"key":"2021122506215269900_onco12710-bib-0036","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1089\/jpm.2015.0459","article-title":"A patient-reported outcome instrument to facilitate timing of end-of-life discussions among patients with advanced cancers","volume":"19","author":"Goldberg","year":"2016","journal-title":"J Palliat Med"},{"key":"2021122506215269900_onco12710-bib-0037","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1200\/JCO.1991.9.9.1618","article-title":"Survival determinants in extensive-stage non-small-cell lung cancer: The Southwest Oncology Group experience","volume":"9","author":"Albain","year":"1991","journal-title":"J Clin Oncol"},{"key":"2021122506215269900_onco12710-bib-0038","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1002\/1097-0142(19840501)53:9<2002::AID-CNCR2820530933>3.0.CO;2-W","article-title":"The Karnofsky Performance Status Scale. An examination of its reliability and validity in a research setting","volume":"53","author":"Mor","year":"1984","journal-title":"Cancer"},{"key":"2021122506215269900_onco12710-bib-0039","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s002800000176","article-title":"Predictive factors of response to cisplatin-based chemotherapy and the relation of response to survival in patients with metastatic urothelial cancer","volume":"46","author":"Sengel\u00f8v","year":"2000","journal-title":"Cancer Chemother Pharmacol"},{"key":"2021122506215269900_onco12710-bib-0040","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1038\/sj.bjc.6601231","article-title":"Performance status score: Do patients and their oncologists agree?","volume":"89","author":"Blagden","year":"2003","journal-title":"Br J Cancer"},{"key":"2021122506215269900_onco12710-bib-0041","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1001\/jama.284.19.2476","article-title":"Factors considered important at the end of life by patients, family, physicians, and other care providers","volume":"284","author":"Steinhauser","year":"2000","journal-title":"JAMA"},{"key":"2021122506215269900_onco12710-bib-0042","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1093\/eurpub\/cku026","article-title":"Burden on family carers and care-related financial strain at the end of life: A cross-national population-based study","volume":"24","author":"Pivodic","year":"2014","journal-title":"Eur J Public Health"},{"key":"2021122506215269900_onco12710-bib-0043","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1097\/01.MLR.0000093487.78664.3C","article-title":"The Patient Health Questionnaire-2: Validity of a two-item depression screener","volume":"41","author":"Kroenke","year":"2003","journal-title":"Med Care"},{"key":"2021122506215269900_onco12710-bib-0044","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1007\/s00520-012-1712-4","article-title":"Clinic-based depression screening in lung cancer patients using the PHQ-2 and PHQ-9 depression questionnaires: A pilot study","volume":"21","author":"Randall","year":"2013","journal-title":"Support Care Cancer"},{"key":"2021122506215269900_onco12710-bib-0045","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1017\/S1478951513000394","article-title":"Comparing the distress thermometer (DT) with the patient health questionnaire (PHQ)-2 for screening for possible cases of depression among patients newly diagnosed with advanced cancer","volume":"12","author":"Lazenby","year":"2014","journal-title":"Palliat Support Care"},{"issue":"suppl 26","key":"2021122506215269900_onco12710-bib-0046","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1200\/jco.2016.34.26_suppl.85","article-title":"Validation of the Living With Cancer (LWC) PRO tool for identifying patients (pts) with cancer appropriate for end-of-life care consultations","volume":"34","author":"Paramanathan","year":"2016","journal-title":"J Clin Oncol"},{"issue":"suppl 15","key":"2021122506215269900_onco12710-bib-0047","doi-asserted-by":"crossref","first-page":"10065a","DOI":"10.1200\/JCO.2016.34.15_suppl.10065","article-title":"Are patients with advanced cancer concerned about financial toxicity?","volume":"34","author":"Paramanathan","year":"2016","journal-title":"J Clin Oncol"},{"issue":"suppl 8","key":"2021122506215269900_onco12710-bib-0048","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1200\/JCO.2017.35.8_suppl.150","article-title":"Identifying latent factors in the Living With Cancer (LWC) patient-reported outcomes (PRO) tool for patients with advanced malignancies","volume":"35","author":"Paramanathan","year":"2017","journal-title":"J Clin Oncol"},{"key":"2021122506215269900_onco12710-bib-0049","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1056\/NEJMoa1000678","article-title":"Early palliative care for patients with metastatic non-small-cell lung cancer","volume":"363","author":"Temel","year":"2010","journal-title":"N Engl J Med"},{"key":"2021122506215269900_onco12710-bib-0050","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1016\/S0140-6736(13)62416-2","article-title":"Early palliative care for patients with advanced cancer: A cluster-randomised controlled trial","volume":"383","author":"Zimmermann","year":"2014","journal-title":"Lancet"},{"key":"2021122506215269900_onco12710-bib-0051","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1001\/jama.2016.16840","article-title":"Association between palliative care and patient and caregiver outcomes: A systematic review and meta-analysis","volume":"316","author":"Kavalieratos","year":"2016","journal-title":"JAMA"},{"key":"2021122506215269900_onco12710-bib-0052","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.1200\/JCO.2017.75.2311","article-title":"Patient-clinician communication: American Society of Clinical Oncology Consensus Guideline","volume":"35","author":"Gilligan","year":"2017","journal-title":"J Clin Oncol"},{"key":"2021122506215269900_onco12710-bib-0053","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1001\/jama.300.14.1665","article-title":"Associations between end-of-life discussions, patient mental health, medical care near death, and caregiver bereavement adjustment","volume":"300","author":"Wright","year":"2008","journal-title":"JAMA"},{"key":"2021122506215269900_onco12710-bib-0054","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1001\/archinte.1992.00400150012003","article-title":"Rationing, patient preferences, and cost of care at the end of life","volume":"152","author":"Singer","year":"1992","journal-title":"Arch Intern Med"}],"container-title":["The Oncologist"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1634\/theoncologist.2018-0238","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1634\/theoncologist.2018-0238","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/oncolo\/article-pdf\/24\/1\/76\/41917424\/oncolo_24_1_76.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/oncolo\/article-pdf\/24\/1\/76\/41917424\/oncolo_24_1_76.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,25]],"date-time":"2021-12-25T06:22:46Z","timestamp":1640413366000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/oncolo\/article\/24\/1\/76\/6439050"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,28]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,9,28]]},"published-print":{"date-parts":[[2019,1,1]]}},"URL":"https:\/\/doi.org\/10.1634\/theoncologist.2018-0238","relation":{},"ISSN":["1083-7159","1549-490X"],"issn-type":[{"value":"1083-7159","type":"print"},{"value":"1549-490X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,1,1]]},"published":{"date-parts":[[2018,9,28]]}}}